Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1 | AVESİS

Bilecik Şeyh Edebali University Research Information System

Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1

Copy For Citation

GÜVENİR ÇELİK E., EROĞLU O.

26. Ulusal Elektron Mikroskopi Kongresi, Turkey, 20 - 23 September 2023, (Summary Text)

Publication Type: Conference Paper / Summary Text
Country: Turkey
Bilecik Şeyh Edebali University Affiliated: Yes